Codelivery of dual drugs from polymeric micelles for simultaneous targeting of both cancer cells and cancer stem cells. (September 2015)

• Record Type: Journal Article
• Authors: Krishnamurthy, Sangeetha; Ng, Victor WL; Gao, Shujun; Tan, Min-Han; Hedrick, James L; Yang, Yi Yan
• Is Part Of: Nanomedicine. Volume 10:Number 18(2015)
• Page Start: 2819
• Page End: 2832
• Publication Date: 2015-09
• Subjects: cancer stem cells -- codelivery -- gemcitabine -- in vivo efficacy -- lung cancer -- micellar nanoparticles -- phenformin; Nanotechnology -- Periodicals; Medical technology -- Periodicals; Nanotechnology -- Therapeutic use -- Periodicals; 610.28
• DOI: 10.2217/nnm.15.109
• Languages: English
• ISSNs: 1743-5889

Abstract

Aim: Phenformin-loaded micelles (Phen M) were used in combination with gemcitabine-loaded micelles (Gem M) to study their combined effect against H460 human lung cancer cells and cancer stem cells (CSCs) in vitro and in vivo .Materials & methods: Gem M and Phen M were prepared via self-assembly of a mixture of a diblock copolymer of PEG and urea-functionalized polycarbonate (PEG-PUC) and a diblock copolymer of PEG and acid-functionalized polycarbonate (PEG-PAC) through hydrogen bonding and ionic interactions. Gem M and Phen M were characterized and tested for efficacy both in vitro and in vivo against cancer cells and CSCs.Results: The combination of Gem M/Phen M exhibited higher cytotoxicity against CSCs and non-CSCs than Gem M and Phen M alone, and showed significant cell cycle growth arrest in vitro . The combination therapy had superior tumor suppression and apoptosis in vivo without inducing toxicity to liver and kidney.Conclusion: The combination of Gem M and Phen M may be potentially used in lung cancer therapy.